Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics

Romeo, Raffaello; Scalisi, Carmelita; Tafuri, Laura; Romeo, Andrea; Maugeri, D.; Sorace, R

doi:10.1016/j.archger.2009.02.008

Cited by 5 publications

(3 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…41 CRP levels have also been shown to predict mortality in patients with dilated cardiomyopathy and to have an inverse association with left ventricular function in patients with HF. 5051 If CRP levels are increased in patients affected by HF, they will further increase with the severity of the pathology and be associated with a higher rate of mortality independently of any ischemic cause. 51, 52 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Lycopene Dietary Intervention

Biddle

Lennie

Bricker

et al. 2015

Journal of Cardiovascular Nursing

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

“…5051 If CRP levels are increased in patients affected by HF, they will further increase with the severity of the pathology and be associated with a higher rate of mortality independently of any ischemic cause. 51, 52 …”

Section: Discussionmentioning

confidence: 99%

Lycopene Dietary Intervention

Biddle

Lennie

Bricker

et al. 2015

Journal of Cardiovascular Nursing

View full text Add to dashboard Cite

“…32,33 If CRP levels are increased in patients with HF, they will further increase with the severity of the pathology and be associated with a higher rate of mortality independently of any ischemic cause. 33,34 Our data also indicate that increased consumption of lycopene-containing food products results in increased plasma levels of lycopene. These data support previous studies where increased dietary intake of lycopene is reflected in increased circulating lycopene levels in plasma.…”

Section: Discussionmentioning

confidence: 99%

Effect of dietary lycopene on inflammatory marker in patients of heart failure

Chauhan

Shah

2015

Int J Res Med Sci

View full text Add to dashboard Cite

GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes

2015

View full text Add to dashboard Cite

Background GlycA is a nuclear magnetic resonance derived signal that originates from oligosaccharide chains of acute phase proteins. The object of this study is to characterize GlycA levels in hospitalized non-critically ill patients with type 2 diabetes. Methods This study evaluated traditional and novel (GlycA) inflammatory markers among 121 patients who were stratified by admission diagnoses: congestive heart failure (CHF), cardiac non-CHF (CARD), infection (INF), and other (OTH). Results HbA1c was similar across groups (8.0-9.2%, p=0.20). Inflammatory markers were elevated but varied significantly across disease categories, with the highest values of interleukin-6 (IL-6), c-reactive protein (CRP), and GlycA in the INF group and the highest tumor necrosis factor-α and intracellular adhesion molecule-1 levels in CHF group. GlycA was associated with higher IL-6 and CRP, lower hemoglobin and lower glomerular filtration rate. GlycA and other inflammatory markers were not significantly associated with admission glucose or HbA1c. Conclusions Among hospitalized non-critically ill patients with type 2 diabetes, GlycA was highest in INF patients and was associated with IL-6 and CRP. None of the markers were significant predictors of glucose control.

show abstract

Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics

Cited by 5 publications

References 34 publications

Lycopene Dietary Intervention

Lycopene Dietary Intervention

Effect of dietary lycopene on inflammatory marker in patients of heart failure

GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes

Contact Info

Product

Resources

About